AYTU BioPharma
AYTU
10 hedge funds and large institutions have $839K invested in AYTU BioPharma in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.
158% more capital invested
Capital invested by funds: $325K → $839K (+$514K)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
25% more funds holding
Funds holding: 8 → 10 (+2)
0.03% more ownership
Funds ownership: 0.03% → 0.06% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$528K |
| 2 |
AC
Armistice Capital
New York
|
+$110K |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$98.7K |
| 4 |
Renaissance Technologies
New York
|
+$86.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$74.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$36K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| 3 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$6K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$220 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $408K | +$528K | +2,398 | +1,355% |
|
|
AC
2
Armistice Capital
New York
| $79K | +$110K | +500 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $75K | +$74.4K | +338 | +245% |
|
|
4
Renaissance Technologies
New York
| $75K | +$86.6K | +393 | +473% |
|
|
WC
5
Wexford Capital
West Palm Beach,
Florida
| $71K | +$98.7K | +448 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $43K | +$60.1K | +273 | New |
|
7
Hudson Bay Capital Management
Stamford,
Connecticut
| $35K | +$49.1K | +223 | New |
|
8
Citadel Advisors
Miami,
Florida
| $22K | +$31.1K | +141 | New |
|
|
ARTA
9
A.R.T. Advisors
New York
| $19K | +$26.4K | +120 | New |
|
10
Acadian Asset Management
Boston,
Massachusetts
| $11K | – | – | – |
|
11
Group One Trading
Chicago,
Illinois
| $1K | – | – | – |
|
|
AIM
12
Alambic Investment Management
Belvedere,
California
| – | -$36K | -66 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$23K | -42 | Closed |
|
|
NMC
14
NEA Management Company
Timonium,
Maryland
| – | -$6K | -11 | Closed |
|
|
15
Bank of America
Charlotte,
North Carolina
| – | -$220 | -1 | Closed |
|
AYTU Hedge Fund Activity: Q4 2018 in Review
10 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q4 2018, worth a combined $839K — up 158% from $325K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AYTU positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, adding an estimated $528K. The largest seller was Alambic Investment Management, exiting entirely with an estimated $36K sold.
- 10 institutional investors held AYTU BioPharma (AYTU) as of Q4 2018, up from 8 in Q3 2018.
- Funds reported $839K of AYTU BioPharma stock for Q4 2018, up 158% quarter-over-quarter.
- 6 funds opened new AYTU BioPharma positions in Q4 2018 and 4 closed out, a net change of +2 holders.
- The largest AYTU BioPharma buyer in Q4 2018 was Sabby Management, an estimated $528K added.
- The largest AYTU BioPharma seller in Q4 2018 was Alambic Investment Management, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2018.